Purdue tests oxycodone on children for new version of drug

For the past year, Purdue Pharma, makers of OxyContin, has been conducting clinical trials for the possible release of Oxycodone for children with moderate to sever chronic pain. According to this release from ClinicalTrials.gov, Purdue is currently recruiting study participants for the trails, estimated to wrap up in September this year. Apparently, Purdue plays by the adage, “Get ’em while they’re young.”

About Dana Owens

Dana Owens is San Francisco-based writer, editor and blogger who works on diverse projects from holistic health research to record label promotion. In addition to lending her editorial eye to Oxy Watchdog, Dana also acts as copyeditor for 99 Series, Inc. and executive assistant/project coordinator for Heartline Productions.
This entry was posted in Informational, Pain Advocates and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *